Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:45 PM
Ignite Modification Date:
2025-12-24 @ 10:45 PM
NCT ID:
NCT03370835
Eligibility Criteria:
Inclusion Criteria:
* 40 years of age or older
* Mild to moderate COPD as defined by the American Thoracic Society
* Current treatment with a beta-blocker for either hypertension, myocardial infarction, or congestive heart failure.
Exclusion Criteria:
* Recent (within 30 days) COPD exacerbation or requirement for oral steroid therapy within the last 6 months
* Any history of ventilator support requirement for COPD
* Patients with asthma or reactive airway disease (RAD) defined as obstructive lung disease with a \>15% improvement in FEV1 with beta-agonist therapy
* Relative or absolute contraindication to beta-blocker therapy
* Exposure to any investigational drugs within the previous 30 days
* Patients with any concurrent disease or condition, which in the judgment of the investigator would make the patient inappropriate for participation in the study were excluded from this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT03370835
Study Brief:
Protocol Section:
NCT03370835